Amgen Donates $1 Million Toward ¶¶ÒõÂÃÐÐÉä-Boulder Biotechnology Building
Amgen Donates $1 Million Toward ¶¶ÒõÂÃÐÐÉä-Boulder Biotechnology Building
January 14, 2010
Ìý
Amgen, a global biotechnology company with manufacturing operations in Boulder and Longmont, is giving $1 million toward the Jennie Smoly Caruthers Biotechnology Building, a state-of-the-art research and teaching facility under construction at the University of Colorado at Boulder.
The first phase of the 257,000-square-foot building on ¶¶ÒõÂÃÐÐÉä-Boulder's East Campus, northwest of Colorado Avenue and the Foothills Parkway, is slated for completion in late 2011. The facility will house the university's Colorado Initiative in Molecular Biotechnology, or CIMB, the department of chemical and biological engineering, and the biochemistry division of the department of chemistry and biochemistry.
The building has been instrumental in helping CIMB recruit a "dream team" of scientists and engineers led by ¶¶ÒõÂÃÐÐÉä-Boulder Distinguished Professor Thomas Cech, a 1989 Nobel laureate in chemistry and former president of the Howard Hughes Medical Institute.
"Dr. Cech has not only been a leader in his field, but has advanced opportunities for research for students throughout his career," said Dave Bengston, vice president of Colorado site operations at Amgen. "Amgen's grant demonstrates our confidence in Dr. Cech's vision to further enhance research opportunities for undergraduates and aligns with our company's commitment to advancing science education and biotechnology research."
Ìý
More formÌý